New hope for rare tumors: drug may slow cancer growth
Disease control
Ongoing
This study tests a drug called lanreotide in 10 people with advanced or metastatic paraganglioma or pheochromocytoma, rare tumors that release hormones. The goal is to see if lanreotide can slow tumor growth compared to before treatment. Participants receive injections every 4 we…
Phase: PHASE2 • Sponsor: Antonio Fojo • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC